PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-TNF MONOCLONAL ANTIBODIES FOR THE TREATMENT OF ACUTE CARDIAC INFARCE AND ITS CO

摘要

The present invention relates to the use of monoclonal anti-TNF antibodies for the treatment of ischaemias, in particular of acute myocardial infarct and the concomitant phenomena associated therewith, such as arrhythmias and tissue damage, in particular to their use in pharmaceutical compositions for reducing arrhythmias, reducing infarct size and increasing the survival rate after myocardial infarct.